Skip to content
Contact
Keep up-to-date
with us
Drive For Change: a white paper on overcoming the barriers to orphan drug development
-
12/06/2026
Volv Global Poster: Real-World Endpoint Mapping and Identification of Evolving Phenotypes of Pompe Disease using Machine Learning
-
02/06/2026
Press release: Machine Learning Maps and Discovers Clinical Endpoints in Pompe Disease Using Real-World Data
-
01/06/2026
Volv Global at Tech Tour Growth Health 2026
-
18/05/2026
Volv Global at the Life Sciences Innovation & Investment Corridor: Lausanne & London
-
17/04/2026
News article: When science fiction becomes science fact – AI for rare disease diagnosis
-
02/04/2026
Volv Global at ISPOR Global 2026, presenting new research in collaboration with Sanofi
-
31/03/2026
Steroids Are the Red Flag in IBD Care That We Keep Ignoring
-
19/03/2026
Advocacy in rare disease: Driving technology advances – 2023 Webinar
-
02/03/2026
Reflecting on Rare Disease Day: Awareness is an Act of Love – Guest Article by Rareatives
-
23/02/2026
How we help you
Clinical Development
Value and Access, HEOR
Medical Affairs
Commercial Excellence
inTrigue
inTrigue
What we do
Finding patients
Earlier detection
Predicting patient outcomes
Stratifying patient cohorts
Knowledge Hub
Insights
Case Studies
Events
News
Articles
Patient Resources
Meet Volv Global
Meet Volv Global
FAQ
How we help you
Clinical Development
Value and Access, HEOR
Medical Affairs
Commercial Excellence
inTrigue
What we do
Finding patients
Earlier detection
Predicting patient outcomes
Stratifying patient cohorts
Knowledge Hub
Insights
Case Studies
Events
News
Articles
Patient Resources
Meet Volv Global
Meet Volv Global
FAQ